Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced a new presentation of Otulfi® ...

The company’s latest preview report projects a guarded rebound for biopharma, as investor confidence returns and M&A activity ...

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...

Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.

Aurobindo Pharma subsidiary CuraTeQ Biologics and U.S. firm BioFactura have terminated their agreement relating to BFI-751, a proposed biosimilar to Janssen Biotech’s Stelara (Ustekinumab). The ...

A novel treatment that uses a disintegrating matrix for sustained release of medication led to improvement in vision and reduced supplemental treatment in patients with diabetic macular edema, ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

Samsung Bioepis Co., Ltd. today announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', a biosimilar referencing Stelara 1 (ustekinumab), developed by Samsung ...

Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...

Mounjaro (tirzepatide) is a prescription medication used with diet and exercise to help adults with type 2 diabetes manage blood sugar levels. Mounjaro comes as an injection given under the skin.

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...